/

Empresas

Gi

No verificado

Gibbs Mura

Sobre qué escribimos

Asociaciones/ProfesionalesLegislación/Derecho

15 Comunicados de prensa

Ver todos los comunicados de prensa

14/11/2025

Legislación/Derecho

Asociaciones/Profesionales

Ardent Health, Inc. (ARDT) Under Investigation After Shares Plummet Over 33%

Fuente

Editor

1.00

0

12/11/2025

Asociaciones/Profesionales

Legislación/Derecho

Lawsuit Filed Against Stride, Inc. (LRN) After Shares Plummet Over 51%

Fuente

Editor

1.00

0

30/09/2025

Asociaciones/Profesionales

Legislación/Derecho

Rezolve AI Accused of Overstating Revenue and Artificial Intelligence Capabilities; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

10/09/2025

Asociaciones/Profesionales

Legislación/Derecho

Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

06/09/2025

Asociaciones/Profesionales

Legislación/Derecho

Super X AI Technology Limited (SUPX) Accused by J Capital Research of Faking AI Infrastructure; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

05/08/2025

Asociaciones/Profesionales

Legislación/Derecho

Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery

Fuente

Editor

1.00

0

21/07/2025

Asociaciones/Profesionales

Legislación/Derecho

Gibbs Mura Announces a Securities Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR); CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

11/07/2025

Asociaciones/Profesionales

Legislación/Derecho

Capricor Therapeutics, Inc. (NASDAQ: CAPR) Securities Fraud Investigation; CAPR Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

26/06/2025

Asociaciones/Profesionales

Legislación/Derecho

Hims & Hers Health, Inc. (NYSE: HIMS) Accused of “Illegal Mass Compounding and Deceptive Marketing” Practices; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

04/06/2025

Legislación/Derecho

Asociaciones/Profesionales

Abacus Global Management, Inc. (NASDAQ: ABL) Under Investigation Following “Fake Revenue” Allegations; Investors Urged to Contact Award-Winning Firm, Gibbs Mura

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0